Genmab A (GMAB) Accumulated Depreciation & Amortization (2023 - 2025)

Genmab A's Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 45.45% year-over-year to $16.0 million; the TTM value through Dec 2025 reached $16.0 million, up 45.45%, while the annual FY2025 figure was $16.0 million, 45.45% up from the prior year.
  • Accumulated Depreciation & Amortization reached $16.0 million in Q4 2025 per GMAB's latest filing, up from $11.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $16.0 million in Q4 2025 to a low of $8.0 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 3 years is $11.7 million, with a median of $11.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 37.5% in 2024, then surged 45.45% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $8.0 million in 2023, then soared by 37.5% to $11.0 million in 2024, then soared by 45.45% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Accumulated Depreciation & Amortization are $16.0 million (Q4 2025), $11.0 million (Q4 2024), and $8.0 million (Q4 2023).